Rite Aid Corporation (NYSE: RAD) Stock Competitors & Peer Comparison
See RAD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RAD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RAD | $0.65 | -16.81% | 36.8M | -0.05 | -$14.34 | N/A |
| RPRX | $56.77 | -0.86% | 25.2B | 10.81 | $5.25 | +1.60% |
| CORT | $110.77 | +2.61% | 12B | 316.49 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $90.22 | +0.89% | 8B | 644.43 | $0.14 | N/A |
| KNSA | $76.06 | -0.59% | 5.8B | 84.51 | $0.90 | N/A |
| TRLV | $8.75 | -2.78% | 1.5B | -20.83 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| CUVL | $6.68 | -0.65% | 336.6M | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
RAD vs RPRX Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, RPRX has a market cap of 25.2B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while RPRX trades at $56.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 10.81. In terms of profitability, RAD's ROE is +2.76%, compared to RPRX's ROE of +0.11%. Regarding short-term risk, RAD is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
RAD vs CORT Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CORT has a market cap of 12B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CORT trades at $110.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 316.49. In terms of profitability, RAD's ROE is +2.76%, compared to CORT's ROE of +0.08%. Regarding short-term risk, RAD is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
RAD vs WBA Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, RAD's ROE is +2.76%, compared to WBA's ROE of -0.42%. Regarding short-term risk, RAD is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
RAD vs LQDA Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LQDA has a market cap of 8B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LQDA trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 644.43. In terms of profitability, RAD's ROE is +2.76%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, RAD is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
RAD vs KNSA Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while KNSA trades at $76.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 84.51. In terms of profitability, RAD's ROE is +2.76%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, RAD is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
RAD vs TRLV Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while TRLV trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas TRLV's P/E ratio is -20.83. In terms of profitability, RAD's ROE is +2.76%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, RAD is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for RAD.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
RAD vs HROWL Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, RAD is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
RAD vs HROWM Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, RAD is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWM's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
RAD vs CUVL Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CUVL has a market cap of 336.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CUVL trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CUVL's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
RAD vs LFMD Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LFMD has a market cap of 172.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LFMD trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LFMD's P/E ratio is -7.12. In terms of profitability, RAD's ROE is +2.76%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, RAD is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
RAD vs LFMDP Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LFMDP has a market cap of 160M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LFMDP trades at $23.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LFMDP's P/E ratio is -722.96. In terms of profitability, RAD's ROE is +2.76%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, RAD is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
RAD vs CIRC Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CIRC has a market cap of 65.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CIRC trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CIRC's P/E ratio is -1.64. In terms of profitability, RAD's ROE is +2.76%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, RAD is more volatile compared to CIRC. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CIRC's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
RAD vs GLTO Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, RAD's ROE is +2.76%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, RAD is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for RAD.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
RAD vs SCYX Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SCYX has a market cap of 33M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SCYX trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.53. In terms of profitability, RAD's ROE is +2.76%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, RAD is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
RAD vs NSRX Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, NSRX has a market cap of 29.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while NSRX trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -4.80. In terms of profitability, RAD's ROE is +2.76%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, RAD is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check NSRX's competition here
Stablecoin Development Corp. (AMEX: SDEV)
RAD vs SDEV Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SDEV has a market cap of 28.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SDEV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SDEV's P/E ratio is -0.18. In terms of profitability, RAD's ROE is +2.76%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, RAD is more volatile compared to SDEV. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SDEV's competition here
Biofrontera Inc. (NASDAQ: BFRI)
RAD vs BFRI Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BFRI has a market cap of 16.3M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BFRI trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -1.19. In terms of profitability, RAD's ROE is +2.76%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, RAD is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
RAD vs CJJD Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, RAD's ROE is +2.76%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, RAD is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
RAD vs SSY Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, RAD's ROE is +2.76%, compared to SSY's ROE of -0.09%. Regarding short-term risk, RAD is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for RAD.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
RAD vs POM Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, POM has a market cap of 5.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POM trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.17. In terms of profitability, RAD's ROE is +2.76%, compared to POM's ROE of +0.16%. Regarding short-term risk, RAD is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
RAD vs PAVS Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, PAVS has a market cap of 5.3M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PAVS trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.07. In terms of profitability, RAD's ROE is +2.76%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, RAD is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
RAD vs HKPD Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HKPD's P/E ratio is -7.01. In terms of profitability, RAD's ROE is +2.76%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, RAD is more volatile compared to HKPD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
RAD vs AIXC Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, AIXC has a market cap of 4.3M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while AIXC trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas AIXC's P/E ratio is -0.09. In terms of profitability, RAD's ROE is +2.76%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, RAD is more volatile compared to AIXC. This indicates higher risk in terms of short-term price fluctuations for RAD.Check AIXC's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
RAD vs MDVL Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas MDVL's P/E ratio is -0.05. In terms of profitability, RAD's ROE is +2.76%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, RAD is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for RAD.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
RAD vs ATNFW Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, RAD is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
RAD vs BGMSP Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, RAD's ROE is +2.76%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, RAD is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
RAD vs BGMS Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMS trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.26. In terms of profitability, RAD's ROE is +2.76%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, RAD is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
RAD vs AZNH Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, RAD's ROE is +2.76%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, RAD is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
RAD vs LFLYW Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, RAD's ROE is +2.76%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, RAD is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
RAD vs SBFMW Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SBFMW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SBFMW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, RAD is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for RAD.Check SBFMW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
RAD vs ESRX Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, RAD's ROE is +2.76%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, RAD is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
RAD vs POZN Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, POZN has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to POZN's ROE of +0.61%. Regarding short-term risk, RAD is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for RAD.Check POZN's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
RAD vs OREX Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, OREX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, RAD's ROE is +2.76%, compared to OREX's ROE of -0.54%. Regarding short-term risk, RAD is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for RAD.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
RAD vs IPXL Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, RAD's ROE is +2.76%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, RAD is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check IPXL's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
RAD vs CPD Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CPD has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CPD's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
RAD vs SHPG Comparison August 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, RAD's ROE is +2.76%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, RAD is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SHPG's competition here